Navigation Links
FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs

American drug market watchdog Food and Drug Administration had announced a series of changes to be followed for// the drugs in the class of non-steroidal anti-inflammatory drugs that are sold with or without prescription over the counter. These changes include the withdrawal of the drug Bextra (valdecoxib) from Pfizer, Inc.

Pfizer, Inc was asked to withdraw the drug Bextra as FDA had reports that the overall risk associated with the drug overshadows the benefits. FDA had also asked the drug company to change the label of the drug Celebrex (celecoxib) to include in a box some specific warnings about risk of cardiovascular problems and gastrointestinal bleeding because of the usage of the drug.

Manufacturer of other prescription and nonprescription non-steroidal anti-inflammatory drugs (NSAID) were also asked to provide a similar label highlighting the cardiovascular and gastrointestinal risks associated with the use of the said drugs. The makers of over the counter NSAIDs were also asked to provide information about skin reactions and any other information that will help the consumer to use the drug safely.

In addition to the instructions to the drug manufacturers, FDA had also updated the patient and healthcare practitioner fact sheets.

Reference: , non-steroidal anti-inflammatory drugs, NSAID, Celebrex, celecoxib, gastrointestinal risks, cardiovascular risks, FDA

Page: 1

Related medicine news :

1. Lure of the home turf brings back NRI doctors
2. Acupuncture to bring relief to patients with dry mouth
3. Fame brings wealth but not health
4. Study shows that interventions from health workers can bring about changes in asthma causes
5. Education in women brings sounder sleep
6. Cancer drug brings relief to patients of Crohn’s Diseas
7. India’s smallest premature baby brings immense joy to Indian parent
8. Cyclone Glenda brings Threat of Fatal Mosquito–borne Diseas
9. E-gym is the latest fad: bring the gym home online!
10. Magic mushrooms known to bring relief to patients
11. Anti-smoking efforts bring down cancer death rates
Post Your Comments:

(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
Breaking Medicine Technology: